Stephen M. Spindel

https://assets.montefioreeinstein.org/profiles/images/Spindel_Stephen_MD_2x_v2.jpg

First Name

Stephen

Last Name

Spindel

NPI

1225386725

Faculty ID

19409

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

201502

Biography

<p>Stephen M. Spindel, MD, is an attending surgeon at Montefiore Einstein. Dr. Spindel&rsquo;s primary clinical focus is on the treatment of aortic valve pathology and diseases of the aorta, especially in patients 60 and under, where he performs the Ross procedure or valve-sparing aortic root operations. He also has an interest in mitral valve repair, mainly through a small three-inch incision. He remains an active heart and lung transplantation doctor and performs coronary artery bypass surgery.</p><p>After obtaining his Bachelor of Science in cellular and molecular biology from Tulane University in 2008, Dr. Spindel earned his Doctor of Medicine at Louisiana State University School of Medicine of New Orleans in 2012. He completed his integrated cardiothoracic surgery residency at Mount Sinai School of Medicine in 2018, where he was Chief Resident in his final two years.</p><p>Dr. Spindel&rsquo;s research focus is aligned with his clinical interests, specifically concentrating on diseases of the aortic valve and aorta. He has shared his work through numerous peer-reviewed publications and presentations.</p><p>Dr. Spindel served eight years in the Air Force Reserve and Air National Guard, where he received a National Defense Service Medal, an Armed Forces Reserve Medal and a Global War on Terrorism Service Medal. He also served in relief efforts for hurricanes Katrina and Gustav.</p>

Is Open Scheduling

Off

Tamar B. Nobel

https://assets.montefioreeinstein.org/profiles/images/Nobel_Tamar_MD_2x.jpg

First Name

Tamar

Last Name

Nobel

NPI

1902224413

Faculty ID

18192

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

200211

Biography

<p>Tamar B. Nobel, MD, MPH, is an attending thoracic surgeon at Montefiore Einstein and Assistant Professor, Cardiothoracic and Vascular Surgery and Epidemiology and Population Health at our Albert Einstein College of Medicine. Dr. Nobel&rsquo;s clinical focus centers on thoracic oncology, including minimally invasive surgery for lung and esophageal cancer. She is also interested in mediastinal and chest wall tumors, metastasectomy for lung metastases from other cancers, tracheal disorders and benign esophageal disease.</p><p>After obtaining her Bachelor of Medicine from Case Western Reserve University School of Medicine in 2014, Dr. Nobel completed a general surgery residency at the Icahn School of Medicine at Mount Sinai. During her training, she completed two research years where she worked as a research fellow at Memorial Sloan Kettering while also completing a Master of Public Health and a board-certified preventive medicine residency. She continued her medical training at Memorial Sloan Kettering Cancer Center, where she completed a cardiothoracic surgery fellowship in 2023 and an advanced thoracic surgical oncology fellowship in 2024.</p><p>Through a multi-disciplinary approach using translational science, health services research, process improvement and community outreach, Dr. Nobel uses an epidemiologic framework to examine and improve clinical outcomes for patients in her current thoracic oncology research. Her work has been shared through numerous peer-reviewed publications, editorials and review articles, book chapters, posters and oral and invited presentations.</p><p>Dr. Nobel is board certified in Public Health and General Preventive Medicine and General Surgery. She is a member of several professional societies, including the Society of Thoracic Surgeons and the American Association for Thoracic Surgery, among others. Through a career development award grant from Lungevity for a project called BRONx-TEAM, Dr. Nobel is increasing adjuvant therapy uptake among lung cancer patients at Montefiore Einstein through patient navigation.</p>

Is Open Scheduling

Off

Ibrahim Abdullah

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/2ccb7010-2cca-11ee-a302-dbae841ce7ff.jpg

First Name

Ibrahim

Last Name

Abdullah

NPI

1366509804

Faculty ID

17921

CMO Specialties

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

EMR ID

187050

Is Open Scheduling

Off

Marc Vimolratana

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/58a00310-6a8c-11ec-afc2-e529147b8d1e.jpg

First Name

Marc

Last Name

Vimolratana

NPI

1467870683

Faculty ID

17157

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Vimolratana is a general thoracic surgeon with a clinical focus on thoracic surgical oncology, including minimally invasive surgery for lung and esophageal cancer. His other clinical interests include mediastinal and chest wall tumors, tracheal disorders, thoracic outlet syndrome, and benign esophageal diseases.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Vimolratana&rsquo;s research focuses on improving patient outcomes after complex lung and esophageal surgery. He has shared his findings through publications in peer-reviewed journals and abstracts at national meetings.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

163553

Biography

<p>Marc Vimolratana, MD, MS, is Assistant Professor, Cardiothoracic and Vascular Surgery at Montefiore Einstein. Dr. Vimolratana is a general thoracic surgeon with a clinical focus on thoracic surgical oncology, including minimally invasive surgery for lung and esophageal cancer. His other clinical interests include mediastinal and chest wall tumors, tracheal disorders, thoracic outlet syndrome, and benign esophageal diseases. Dr. Vimolratana takes a patient-centered approach to patient care and is committed to using minimally invasive techniques, including VATS and robotic surgery, whenever possible to minimize surgical trauma and pain for patients.</p><p>Dr. Vimolratana studied chemistry at Yale, earning a Bachelor of Science and Master of Science in 2006. He attended medical school at the University of California, San Francisco, earning a Doctor of Medicine in 2014. After many years in California, he moved to New York for postdoctoral training at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, where he completed a residency in general surgery in 2019, serving as chief resident in his final year. Dr. Vimolratana continued at NewYork-Presbyterian Hospital for fellowship training in cardiothoracic surgery prior to joining the faculty at Montefiore Einstein in 2021.</p><p>Dr. Vimolratana&rsquo;s research focuses on improving patient outcomes after complex lung and esophageal surgery. He has shared his findings through publications in peer-reviewed journals and abstracts at national meetings.</p><p>Dr. Vimolratana is certified by the American Board of Thoracic Surgery and the American Board of Surgery. He is a member of several professional organizations, including the American College of Surgeons, the Society of Thoracic Surgeons and the European Society of Thoracic Surgeons. He has been honored with numerous awards for academic excellence and clinical care.</p>

Is Open Scheduling

Off

Mayuko Uehara

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/bcff6b00-0f0a-11ef-8dfd-d5d86707fe54.jpg

First Name

Mayuko

Last Name

Uehara

NPI

1154888725

Faculty ID

17041

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Cardiovascular Surgery</span><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Uehara&rsquo;s research experience includes a new method for the detection of coronary artery bypass graft using transit time flow measurement (TTFM) and MemCalc software.

Elsevier Profile

EMR ID

113203

Biography

<p>Mayuko Uehara, MD, PhD, is an Attending Cardiothoracic Surgeon and Cardiothoracic Surgery Super Fellow at Montefiore-Einstein. </p>
<p>Dr. Uehara earned her Doctor of Medicine at Shimane Medical University inJapan, and a PhD in Clinical Research of Cardiovascular Surgery at Sapporo Medical University Hospital.. She completed an internship in medicine at Yokosuka Kyosai Hospital, and her residency and clinical fellowship in cardiovascular and thoracic surgery at Sapporo Medical University Hospital. She also completed a research fellowship in transplant immunology and was an instructor in transplant immunology at Brigham and Women&rsquo;s Hospital in Boston.</p>
<p >Dr. Uehara&rsquo;s research experience includes a new method for the detection of coronary artery bypass graft using transit time flow measurement (TTFM) and MemCalc software. She is a member of the Japan Surgical Society, the Japanese Association for Thoracic Surgery, the Japanese Circulation Society, the Japanese Society for Cardiovascular Surgery and the Japanese Society for Vascular Surgery. She is also a member of the American Society of Transplantation, The International Society for Heart and Lung Transplantation, the American Heart Association and the American Society of Transplant Surgeons. Dr. Uehara is a board certified surgeon in the Japan Surgical Society and a board certified cardiovascular surgeon in the Japanese Society for Cardiovascular Surgery. In addition, she is board certified in angiology by the Japanese College of Angiology and board certified by the Educational Commission for Foreign Medical Graduates (ECFMG).</p>

Is Open Scheduling

Off

Tadahisa Sugiura

https://assets.montefioreeinstein.org/profiles/images/physphoto/Sugiura_Tadahisa_MD_420x504.jpg

First Name

Tadahisa

Last Name

Sugiura

NPI

1942704267

Faculty ID

16309

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Sugiura&rsquo;s clinical focus is in structural heart disease, coronary artery bypass surgery, the treatment of end-stage heart failure, extracorporeal membrane oxygenation (ECMO), and cardiothoracic organ procurement.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Sugiura&rsquo;s research focuses on cardiac regenerative therapy, induced pluripotent stem cell (iPS cell) research and stem cell medicine.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

PubMed.gov URL

EMR ID

14130

Biography

<p>Tadahisa Sugiura, MD, PhD, is an attending surgeon and Assistant Professor at Montefiore-Einstein. Dr. Sugiura&rsquo;s clinical focus is in structural heart disease, coronary artery bypass surgery, the treatment of end-stage heart failure, extracorporeal membrane oxygenation (ECMO), and cardiothoracic organ procurement.</p><p>Educated in Japan, Dr. Sugiura attended University of Tsukuba School of Medicine from 1997 to 2003, earning his Doctor of Medicine degree. He began his postdoctoral training with a residency at Tokyo Women&rsquo;s Medical University from 2003 to 2005, followed by a residency at Seirei Hamamatsu General Hospital in Japan from 2005 to 2007. He then undertook a fellowship at Tokyo Women&rsquo;s Medical University in 2008, followed by a fellowship at Yokohama City University Medical Center from 2009 to 2011. In 2012, he earned his PhD from Tokyo Women&rsquo;s Medical University. Dr. Sugiura came to the United States in 2013 and continued his training, completing a research fellowship at Nationwide Children's Hospital, The Ohio State University in 2016. He was an advanced fellow at Texas Heart Institute at Baylor St. Luke&rsquo;s Medical Center from 2016 to 2018 and a super fellow at Montefiore-Einstein from 2018 to 2019.</p><p>Dr. Sugiura&rsquo;s research focuses on cardiac regenerative therapy, induced pluripotent stem cell (iPS cell) research and stem cell medicine. He has shared his research through publication in many peer-reviewed journals as well as book chapters, abstracts, posters and presentations. He is also an ad hoc reviewer for several publications including <em>The Annals of Thoracic Surgery and Internal Medicine</em>.</p><p>Dr. Sugiura is board certified and is a member of several professional societies.</p>

Is Open Scheduling

Off

Brendon M. Stiles

https://assets.montefioreeinstein.org/profiles/images/Stiles_Brendon_MD_2x.jpg

First Name

Brendon

Last Name

Stiles

NPI

1013176387

Faculty ID

16884

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNoSpacing">Brendon Stiles, MD, is Professor and Chief, Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic &amp; Vascular Surgery at Montefiore-Einstein.&nbsp; Dr. Stiles is also the Associate Director for Surgical Services in the Montefiore-Einstein Cancer Center. Dr. Stiles&rsquo; clinical focus is on the treatment of lung and esophageal cancer and on neoadjuvant immunotherapy. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.</p>
<p class="MsoNoSpacing">Dr. Stiles is also heavily involved with translational and basic research.&nbsp; Translationally, Dr. Stiles is interested in neoadjuvant immunotherapy and in predicting and augmenting response to immunotherapy.&nbsp; &nbsp;In the laboratory, he has been funded by the AATS, TSF, the Lung Cancer Research Foundation, the DOD CDMRP Lung Cancer Research Program, and the Mark Foundation.&nbsp;</p>
<p class="MsoNoSpacing">Dr. Stiles' laboratory currently investigates the protein ART1, an extracellular mono-ADP-ribosyltransferase.&nbsp; Recently, Dr. Stiles and his team discovered that ART1 may play an important role in one mechanism of resistance in lung cancers. ART1 mono-ADP-ribosylates the P2X7 receptor (P2X7R) on immune cells, which ultimately causes NAD-induced cell death (NICD) in T cells, macrophages, and dendritic cells. They found ART1 to be highly expressed in multiple human non-small cell lung cancer cell lines and in the majority of human lung adenocarcinomas they sampled.<span style="mso-spacerun: yes;">&nbsp; </span>ART1 expression allows cancers to blunt the immune response against them. Indeed, they found that inhibiting ART1 with a therapeutic monoclonal antibody in mouse models of lung cancer caused a dramatic reduction of tumor burden and an enrichment of immune cells in the tumor.</p>
<p class="MsoNoSpacing"><span style="font-size: 12pt;">Current efforts are underway to better understand regulation of ART1 expression, to identify more targets of extracellular mono-ADP-ribosylation, and to refine pre-clincal models to test their therapeutic antibody targeting ART1.</span></p>
<p class="MsoNoSpacing">&nbsp;</p>
<p class="MsoNoSpacing">&nbsp;</p>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Stiles’ clinical focus is on the treatment of lung and esophageal cancer and on neoadjuvant immunotherapy. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.
</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Stiles&rsquo; clinical focus is on the treatment of lung and esophageal cancer and unusual thoracic cancers including metastatic tumors and those invading the heart. He also has a clinical interest in treating benign chest and upper gastrointestinal diseases.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Stiles is actively involved in both clinical and translational research, particularly focusing on lung cancer. His clinical research concentrates on the management of early stage or screen detected lung cancer and on novel multidisciplinary treatment strategies for patients with lung cancer.&nbsp; In the laboratory, he investigates a protein called ART1 and its role in protecting cancer cells from the immune system. He has developed a novel drug targeting ART1 with a goal of advancing it to clinical use. He has co-authored numerous manuscripts on the management of early stage or screen-detected lung cancer, guidelines for the management of early stage lung cancer, papers regarding neoadjuvant immunotherapy for lung cancer patients and a comprehensive review on the tumor microenvironment in lung cancer.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif;">Wennerberg, Erik et al, Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer.&nbsp;&nbsp;<em>Science Translational Medicine.&nbsp;</em>2022 Mar 16;14(636):eabe8195.&nbsp;&nbsp;</span><u style="font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14px;"><span style="font-size: 11.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; color: #0563c1; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.s…;
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Altorki, Nasser K., et al. "The lung microenvironment: an important regulator of tumour growth and metastasis."&nbsp;</span><em style="font-size: 12pt;"><span style="font-family: Arial, sans-serif;">Nature Reviews Cancer</span></em><span style="font-size: 12pt;">&nbsp;19.1 (2019): 9-31.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Yao, Zhan, et al. "TGF-&beta; IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">Proceedings of the National Academy of Sciences</span></em>&nbsp;107.35 (2010): 15535-15540.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Gao, Dingcheng, et al. "Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">Cancer research</span></em>&nbsp;72.6 (2012): 1384-1394.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Altorki, Nasser K., et al. "Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: A single-centre, randomised phase 2 trial."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">The Lancet Oncology</span></em>&nbsp;22.6 (2021): 824-835.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Wennerberg, Erik, et al. "Expression of ART1, an extracellular mono ADP-ribosylase, promotes lung cancer growth and dissemination by limiting tumor infiltration of P2X7R+ CD8+ T cells and CD103+ dendritic cells."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">JOURNAL FOR IMMUNOTHERAPY OF CANCER</span></em>. Vol. 7. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND: BMC, 2019.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Chen, Chuang, et al. "ART1, an extracellular ADP-ribosyltransferase, is over-expressed in non-small cell lung cancer and facilitates cancer cell survival by immune-mediated mechanisms."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">Journal of Thoracic Oncology</span></em>&nbsp;11.2 (2016): S44.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">https://scholar.google.com/citations?user=fR4OkgkAAAAJ&amp;hl=en&amp;oi…;

EMR ID

82842

Biography

<p>Brendon Stiles, MD, is Professor and Chief, Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic &amp; Vascular Surgery at Montefiore Einstein, and the Associate Director for Surgical Services in the Montefiore Einstein Cancer Center. Dr. Stiles&rsquo; clinical focus is on the treatment of lung and esophageal cancer and unusual thoracic cancers including metastatic tumors and those invading the heart. He also has a clinical interest in treating benign chest and upper gastrointestinal diseases. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.</p><p>&ldquo;The recruitment of&nbsp;Dr. Stiles elevates the treatment of lung cancer to a historic level,&rdquo; said Robert E. Michler, MD, Surgeon-in-Chief and Chairman and Professor, Department of Surgery and Department of Cardiothoracic &amp; Vascular Surgery at Montefiore-Einstein. &ldquo;Every thoracic surgical therapy available anywhere in the world will now be offered by Dr. Stiles at Montefiore-Einstein.&rdquo;</p><p>After earning his Bachelor of Arts in 1994 at the University of Virginia, Dr. Stiles continued at UVA, earning his Doctor of Medicine in 1999.&nbsp; He conducted his training in general surgery at the University of Virginia Health System. From 2001 to 2003, Dr. Stiles served as a surgical research fellow at Memorial Sloan-Kettering Cancer Center before returning to the University of Virginia Health System to complete his surgical residency. Dr. Stiles completed a cardiothoracic surgery residency at NewYork-Presbyterian Hospital-Weill Cornell and Memorial Sloan-Kettering Cancer Center in 2008. Dr. Stiles joined the faculty at NewYork-Presbyterian Hospital-Weill Cornell before being recruited by Dr. Michler to Montefiore-Einstein in 2021.</p><p>Dr. Stiles is actively involved in both clinical and translational research, particularly focusing on lung cancer. His clinical research concentrates on the management of early stage or screen detected lung cancer and on novel multidisciplinary treatment strategies for patients with lung cancer.&nbsp; In the laboratory, he investigates a protein called ART1 and its role in protecting cancer cells from the immune system. He has developed a novel drug targeting ART1 with a goal of advancing it to clinical use. He has co-authored numerous manuscripts on the management of early stage or screen-detected lung cancer, guidelines for the management of early stage lung cancer, papers regarding neoadjuvant immunotherapy for lung cancer patients and a comprehensive review on the tumor microenvironment in lung cancer. In addition to publications in peer-reviewed journals, he has also given several invited national and international talks on his research and on the clinical management of lung and esophageal cancer.</p><p>Dr. Stiles is highly active in the lung cancer care community, having lost his own father to lung cancer in 2005. He is committed to raising money for lung cancer research, serving as chair of the Lung Cancer Research Foundation since 2017. He is also an invited member of the National Lung Cancer Roundtable and on the Lung-RADS Steering Committee for lung cancer screening with the American College of Radiology.&nbsp; Dr. Stiles is a member of several professional organizations including the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, the American Society of Clinical Oncology, the European Society of Thoracic Surgeons and the International Association for the Study of Lung Cancer.</p>

Is Open Scheduling

Off

Robert E. Michler

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4c095d20-b884-11ee-946e-1f574f05546e.jpg

First Name

Robert

Last Name

Michler

NPI

1841370491

Faculty ID

10023

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><a title="View Robert Michler's Montefiore profile" href="https://montefioreeinstein.org/profiles/1841370491/robert-e-michler&quot; target="_blank">Robert E. Michler, MD</a>, has served as the Surgeon-in-Chief of the Montefiore Medical Center since 2008. He is Chairman of the Department of Surgery (2007) and Chairman of the Department of Cardiothoracic &amp; Vascular Surgery (2005) at the Montefiore Medical Center. Dr. Michler holds the Samuel I. Belkin Chair and is Professor with Tenure at the Albert Einstein College of Medicine.</p>
<p>Dr. Michler is an internationally renowned <a title="View Montefiore's heart and surgical service" href="https://montefioreeinstein.org/heart/services/procedures-interventions&…; target="_blank">cardiothoracic surgeon</a> and researcher. He is a highly sought after surgeon and known leader in several surgical specialties, including complex multiprocedural cardiac surgery, mitral and aortic <a title="View Montefiore's heart valve disease and treatment" href="https://montefioreeinstein.org/heart/conditions/heart-valve-diseases&qu…; target="_blank">valve repair surgery</a>, surgery for congestive heart failure, minimally invasive cardiac surgery, and <a title="View Montefiore's hear transplantation" href="https://montefioreeinstein.org/heart/services/programs-centers/cardiolo…; target="_blank">heart transplantation</a>. Of particular note, Dr. Michler was one of the first to perform <a title="View Montefiore's minimally invasive and robot surgery" href="https://montefioreeinstein.org/heart/conditions/heart-valve-diseases&qu…; target="_blank">minimally invasive and robotic surgery</a> in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for <a title="View Montefiore's mitral valve repair" href="https://montefioreeinstein.org/heart/conditions/heart-valve-diseases/mi…; target="_blank">mitral valve repair</a> and coronary artery bypass surgery.</p>
<p>He is an NIH-funded investigator, serving as Principal Investigator for the NIH/NHLBI-sponsored Cardiothoracic Surgical Clinical Trials Network. He has participated in over 50 clinical trials including the use of myoblasts and stem cells for heart failure.</p>
<p>In 2017, Dr. Michler received the Vladimir Borakovsky Prize from the Russian Ministry of Health in Moscow for &ldquo;his personal contributions to the development of cardiovascular surgery&rdquo;.</p>
<p>Dr. Michler lectures extensively, both nationally and abroad, and is a regular Expert Opinion author on heart related topics including stem cell therapies, ischemic mitral regurgitation and ischemic heart failure. Over the years, Dr. Michler has provided regular commentary to NBC Nightly News, the New York Times and the Wall Street Journal.</p>
<p>In his unique role as Chairman of both the Department of Surgery and the Department of Cardiothoracic &amp; Vascular Surgery, Dr. Michler applies his dynamic leadership to expand Montefiore-Einstein's role at the forefront of surgical innovation. In 2017, he was responsible for establishing the Lung and Heart-Lung transplantation and end stage pulmonary failure program at Montefiore-Einstein.</p>
<p>Formerly, Dr. Michler held the John G. and Jeanne Bonnet McCoy Endowed Chair, tenured Professor of Surgery, Chief of Cardiothoracic Surgery and Director of Heart &amp; Lung Transplantation at The Ohio State University Medical Center. He also served as the Associate Director of the Dorothy M. Davis Heart and Lung Research Institute. Dr. Michler was integral to the planning, design, and philanthropic development for the Richard M. Ross Heart Hospital. Dr. Michler served as the first Executive Director of the Richard M. Ross Heart Hospital.</p>
<p>Before joining The Ohio State University faculty, Dr. Michler was a tenured Associate Professor of Surgery at Columbia University and Director of the Heart Transplant Program at Columbia-Presbyterian Medical Center.</p>
<p>Dr. Michler received his undergraduate education <em>Magna Cum Laude</em> from Harvard University. He received his medical education at Dartmouth Medical School where he was a Leopold Schepp Scholar. Dr. Michler completed his residency in General Surgery, a fellowship in Cardiothoracic Transplantation and a fellowship in Cardiothoracic Surgery at the Columbia Presbyterian Medical Center in New York, followed by a fellowship in Pediatric Cardiothoracic Surgery at Boston Children's Hospital, Harvard Medical School.</p>
<p>Dr. Michler has received numerous honors including &ldquo;Person of the Week&rdquo; by ABC World News Tonight, the Pace Humanitarian Award, and &ldquo;The Order of Christopher Columbus&rdquo; by Hippolito Mejia, President of the Dominican Republic.</p>

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt;">Dr. Michler is a heart surgeon who specializes in complex aortic and mitral valve repair surgery. He is an NIH-funded investigator whose interest in repairing the injured heart has led to clinical trials in cardiac stem cell transplantation. Dr. Michler and his teams have advanced minimally invasive cardiothoracic surgery procedures and surgical robotics. This work led to FDA approval for selective cardiac robotic procedures including mitral valve repair and coronary bypass surgery.</span></p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt;">Dr. Michler has authored hundreds of peer-reviewed publications, including in the <em>New England Journal of Medicine</em>,<span>&nbsp;</span><em>Circulation</em><span>&nbsp;</span>and the<span>&nbsp;</span><em>Proceedings of the National Academy of Sciences</em>. He is a frequent editor on cardiac surgery topics and lectures extensively, both nationally and abroad. Dr. Michler is the chairman and founder of a not-for-profit foundation, Heart Care International, which performs pediatric heart surgery in underserved regions of the world. To date, Heart Care International has helped over 1,000 children with heart disease and performed heart surgery on over 600 children. He has received numerous honors including &ldquo;Person of the Week&rdquo; by ABC&rsquo;s<span>&nbsp;</span><em>World News Tonight</em><span>&nbsp;</span>and the Order of Christopher Columbus.</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Coronary Artery Bypass Surgery, Heart Failure Surgery, Heart Transplantation, Minimally Invasive Cardiothoracic Surgery, Surgical Ventricular Reconstruction, Valve Repair Surgery

Research Focus

Dr. Michler and his cardiothoracic surgery team are advancing the use of minimally invasive cardiothoracic surgery procedures including coronary bypass, aortic and mitral valve repair procedures, autologous myoblast and stem cell injection therapy.

Elsevier Profile

Selected Publications

<p>Williams JB, Peterson ED, Brennan JM, Sedrakyan A, Tavris D, Alexander JH, Lopes RD, Dokholyan RS, Zhao Y, O&rsquo;Brien SM, <strong>Michler RE</strong>, Thourani VH, Edwards FH, Gross T, Marinac-Dabic D, Smith PK. Endoscopic Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA. 2012;308(5):475-84.</p>
<p><strong>Michler RE</strong>, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, Holly TA, Oh JK, Dagenais F, Milano C, Wrobel K, Pirk J, Ali IS, Velazquez EJ, Lee KL, Di Donato M. Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013;146(5):1139-1145.</p>
<p><strong>Michler RE</strong>. Surgical Options for the Management of Ischemic Cardiomyopathy.Current Treatment Options in Cardiovascular Medicine. 2013;15(5):518-532.</p>
<p>Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D'Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O'Gara PT, <strong>Michler RE</strong>, Kron IL; the CTSN Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. N Engl J Med. 2014;370(1):23-32.</p>
<p><strong>Michler RE</strong>. Stem cell therapy for heart failure. Cardiol Rev. 2014;22(3):105-16.</p>
<p>Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pag&eacute; P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, <strong>Michler RE</strong>; Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178-88.</p>
<p>&nbsp;</p>

EMR ID

4690

Biography

<p>Connect with Dr. Michler on <strong><a href="http://www.facebook.com/RobertMichlerMD&quot; target="_blank">Facebook</a></strong> | <strong><a href="http://www.twitter.com/RMichlerMD&quot; target="_blank">Twitter</a> | <a href="http://www.youtube.com/robertmichlermd&quot; target="_blank">YouTube</a></strong></p><p>Robert E. Michler, MD, has served as the Surgeon-in-Chief of the Montefiore Medical Center since 2008. He is Chairman of the Department of Surgery (2007) and Chairman of the Department of Cardiothoracic & Vascular Surgery (2005) at the Montefiore Medical Center. Dr. Michler holds the Samuel I. Belkin Chair and is Professor with Tenure at the Albert Einstein College of Medicine.</p><p>Dr. Michler is an internationally renowned <a href="https://www.montefiore.org/heart-surgical-services">cardiothoracic surgeon</a> and researcher. He is a highly sought after surgeon and known leader in several surgical specialties, including complex multi-procedural cardiac surgery, mitral and aortic <a href="https://www.montefiore.org/heart-valve-repair-and-valve-sparing-surgery… repair surgery</a>, surgery for congestive heart failure, minimally invasive cardiac surgery, and <a href="https://www.montefiore.org/heart-transplant">heart transplantation</a>. Of particular note, Dr. Michler was one of the first to perform <a href="https://www.montefiore.org/minimally-invasive-and-robotic-cardiothoraci… invasive and robotic surgery</a> in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for <a href="https://www.montefiore.org/mitral-valve-repair-and-replacement">mitral valve repair</a> and coronary artery bypass surgery.</p><p>He is an NIH-funded investigator, serving as Principal Investigator for the NIH/NHLBI-sponsored Cardiothoracic Surgical Clinical Trials Network. He has participated in over 50 clinical trials including the use of myoblasts and stem cells for heart failure.</p><p>In 2017, Dr. Michler received the Vladimir Borakovsky Prize from the Russian Ministry of Health in Moscow for &ldquo;his personal contributions to the development of cardiovascular surgery&rdquo;.</p><p>Dr. Michler lectures extensively, both nationally and abroad, and is a regular Expert Opinion author on heart related topics including stem cell therapies, ischemic mitral regurgitation and ischemic heart failure. Over the years, Dr. Michler has provided regular commentary to NBC Nightly News, the New York Times and the Wall Street Journal.</p><p>In his unique role as Chairman of both the Department of Surgery and the Department of Cardiothoracic & Vascular Surgery, Dr. Michler applies his dynamic leadership to expand Montefiore Einstein's role at the forefront of surgical innovation. In 2017, he was responsible for establishing the Lung and Heart-Lung transplantation and end stage pulmonary failure program at Montefiore Einstein.</p><p>Formerly, Dr. Michler held the John G. and Jeanne Bonnet McCoy Endowed Chair, tenured Professor of Surgery, Chief of Cardiothoracic Surgery and Director of Heart & Lung Transplantation at The Ohio State University Medical Center. He also served as the Associate Director of the Dorothy M. Davis Heart and Lung Research Institute. Dr. Michler was integral to the planning, design, and philanthropic development for the Richard M. Ross Heart Hospital. Dr. Michler served as the first Executive Director of the Richard M. Ross Heart Hospital.</p><p>Before joining The Ohio State University faculty, Dr. Michler was a tenured Associate Professor of Surgery at Columbia University and Director of the Heart Transplant Program at Columbia-Presbyterian Medical Center.</p><p>Dr. Michler received his undergraduate education Magna Cum Laude from Harvard University. He received his medical education at Dartmouth Medical School where he was a Leopold Schepp Scholar. Dr. Michler completed his residency in General Surgery, a fellowship in Cardiothoracic Transplantation and a fellowship in Cardiothoracic Surgery at the Columbia Presbyterian Medical Center in New York, followed by a fellowship in Pediatric Cardiothoracic Surgery at Boston Children's Hospital, Harvard Medical School.</p><p>Dr. Michler has received numerous honors including &ldquo;Person of the Week&rdquo; by ABC World News Tonight, the Pace Humanitarian Award, and &ldquo;The Order of Christopher Columbus&rdquo; by Hippolito Mejia, President of the Dominican Republic.</p><p><a href="https://www.montefiore.org/body.cfm?id=1729">View Dr. Michler's online CV.</a></p>

Is Open Scheduling

Off

William A. Jakobleff

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/df8ea6c0-f8c0-11ec-9cb7-15f799598473.jpg

First Name

William

Last Name

Jakobleff

NPI

1346469251

Faculty ID

13923

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4897

Is Open Scheduling

Off

Daniel J. Goldstein

https://assets.montefioreeinstein.org/profiles/images/physphoto/Goldstein_Daniel_MD_420x504.jpg

First Name

Daniel

Last Name

Goldstein

NPI

1043390693

Faculty ID

10709

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Coronary Artery Bypass Surgery, Off Pump Revascularization, Surgical Management of End Stage Heart Disease, Cardiac Transplantation , Surgical Ventricular Reconstruction, Mechanical Support of the Circulation, Mitral Valve Surgery</p>

Research Focus

Dr. Goldstein's research interests lie in the understanding of left ventricular recovery following institution of mechanical support in patients with advanced heart failure. He is also actively involved in the evaluation of new ventricular assist devices.

Elsevier Profile

Selected Publications

<p>&nbsp;</p>
<p style="font-family: 'Times New Roman'; margin-left: 0in; font-size: 12.0pt; margin-bottom: .0001pt; margin-right: 0in; margin-top: 0in;"><strong>Journal Articles</strong></p>
<p style="text-indent: -1.25in;">&nbsp;</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">1.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Zaghouani H, <strong>Goldstein DJ</strong>, Shah H, Anderson S, Lacroix M., Kennedy R, Bona C. <em>Induction of antibodies to the envelope protein of the HIV virus by sensitization of rabbits with monoclonal anti-idiotypes</em>. Proc Nat Acad Sci 1991;88(13):5645-49.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">2.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Oz MC, <strong>Goldstein DJ</strong>, Rose EA. <em>Adjustable annuloplasty for tricuspid insufficiency</em>. Ann Thorac Surg 1994;58:594-95.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">3.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, El-Amir N, Ashton RA, Catanese K,&nbsp; Rose EA, Levin HR , Oz MC. <em>Fungal infections in left ventricular assist device recipients: incidence, prophylaxis and treatment.</em> ASAIO 1995;41:873-75.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">4.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Oz MC, Rose EA, Fisher P, Michler RE<em>.</em> <em>Experience with heart transplantation for cardiac tumors</em>. J Heart Lung Transpl 1995;14:382-86.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">5.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Seldomridge JA, Addonizio L, Oz MC, Michler RE. <em>Orthotopic heart transplantation in patients with treated malignancies.</em> Am J Cardiol 1995;75:968-71.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">6.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, Smith CR, Rose EA, Levin HR, Oz MC. <em>Use of aprotinin in LVAD recipients reduces blood loss, blood use and perioperative mortality</em>. Ann Thorac Surg 1995;59:1063-68.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">7.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Mullis SL, Delphin ES, El-amir N, Ashton RC, Gardocki M, Jordan DA, Catanese KA, Levin HR, Oz MC. <em>Non cardiac surgery in long term implantable LVAD recipients</em>. Ann Surg 1995;222:203-07.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">8.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Slater JP, <strong>Goldstein DJ</strong>, Ashton RC, Levin HR, Spotnitz HM, Oz MC. <em>Right-to-left venoarterial shunting for right sided circulatory failure</em>. Ann Thorac Surg 1995;60:978-85.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">9.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE. <em>De novo malignancies after orthotopic cardiac transplantation</em>. Ann Thorac Surg 1995;60:1783-89.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">10.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, DeRosa CM, Mongero L, Weinberg AD, Michler RE, Rose EA, Oz MC, Smith CR. <em>Safety and efficacy of aprotinin in profound hypothermia and circulatory arrest</em>. J Thorac Cardiovasc Surg 1995;110:1615-22.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">11.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Oz MC, <strong>Goldstein DJ</strong>, Pepino P, Weinberg AD, Thompson S, Catanese KA, Vargo RL, McCarthy PM, Rose EA, Levin HR. <em>Screening scale predicts patients successfully receiving long-term implantable LVAD.</em> Circulation 1995;92[suppl II]:II-169-II-173</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">12.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Slater JP, Yamada A, Yano OJ, Stennet R, <strong>Goldstein DJ</strong>, Levin HR, Spotnitz HM, Oz MC. <em>Creation of a controlled venoarterial shunt: A surgical intervention for right-sided circulatory failure.</em> Circulation 1995;92[suppl II]:II-467-II-471.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">13.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Oz MC, Michler RE. <em>Radical excisional therapy and cardiac transplantation for recurrent atrial myxoma</em>. Ann Thorac Surg 1995;60:1105-07.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">14.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Oz MC, <strong>Goldstein DJ</strong>, Rose EA. <em>Preperitoneal placement of ventricular assist devices: an illustrated stepwise approach.</em> J Cardiac Surg 1995;10:288-94.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">15.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Rose EA, <strong>Goldstein DJ</strong>. <em>Wearable long term mechanical support for patients with end-stage heart disease: a tenable goal.</em> Ann Thorac Surg 1996;61:399-402.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">16.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Smith CR, Oz MC, Friedlander J, Mongero L, Delphin E.&nbsp; <em>Safety of repeat aprotinin administration for left ventricular assist device recipients undergoing cardiac transplantation.</em> Ann Thorac Surg 1996;61:692-95.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">17.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Austin JHM, Zuech N, Williams DL, Stoopler MB, Michler RE, Schulman LL. <em>Lung cancer after heart transplantation.</em> Transplantation&nbsp; 1996;62(6):772-75.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">18.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Catanese KA, <strong>Goldstein DJ</strong>, Williams DL, Foray AT, Illick CD, Gardocki MT, Weinberg AD, Levin HR, Rose EA, Oz MC. <em>Outpatient left ventricular assist device support: a new destination rather than a bridge.</em> Ann Thorac Surg&nbsp; 1996;62:646-53.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">19.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Beck J, Mongero L, <strong>Goldstein DJ</strong>, Oz MC<em>. Perfusion technique for the treatment of right heart failure</em>. Perfusion 1995;10:323-26.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">20.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Ashton RC, <strong>Goldstein DJ</strong>, Rose EA, Weinberg AD, Levin HR, Oz MC<em>. Duration of LVAD support affects transplant survival</em>. J Heart Lung Transpl 1996;15:1151-57.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">21.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Ashton RC, <strong>Goldstein DJ</strong>, Rose EA, Weinberg AD, Levin HR, Oz MC.&nbsp; <em>The development of a transluminal device for the treatment of aortic regurgitation: prototype and testing system</em>. J Thorac Cardiovasc Surg 1996;112:979-83.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">22.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Oz MC, Argenziano M, Catanese KA, Gardocki M,<strong>Goldstein DJ</strong>, Ashton RC, Rose EA, Levin HR. <em>Bridge experience with long-term implantable left ventricular assist device: are they an alternative to transplantation ?.</em> Circulation 1997;95:1844-52.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">23.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Zuech N, Sehgal V, Weinberg AD, Drusin RE, Cohen D. <em>Cyclosporine induced end stage nephropathy after cardiac transplantation; incidence and progression</em>. Transplantation 1997;63:664-68.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">24.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Holubarsch C, Ruf T, <strong>Goldstein DJ</strong>, Ashton RC,&nbsp; Nickl W, Pieske B, Pioch K, Ludmann J, Wiesner S, Hasenfuss G, Posival H, Just H, Burkhoff D. <em>Existence of the Frank-Starling mechanism in the failing human heart.</em> Circulation 1996;94:683-89.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">25.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Ashton RC, Slater JP, Pearson M, Seldomridge JA, D&rsquo;Alessandro D, Jordan DA, Oz MC. <em>Venoarterial shunting for the treatment of right sided circulatory failure following left ventricular assist device placement.</em> ASAIO J 1997;43(3):171-76.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">26.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Moazami N, Seldomridge JA, Liao H, Ashton RC, Naka Y, Pinsky DJ, Oz MC. <em>Circulatory resuscitation with 30 day left ventricular assist device reduces interleukins 6 and 8 levels</em>. Ann Thorac Surg 1997;63:971-74.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">27.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Dean D, Smerling A, Oz MC, Dickstein M<em>. Inhaled nitric oxide Is not a negative inotrope in a porcine model of pulmonary hypertension</em>. J Thorac Cardiovasc Surg 1997;114:461-66.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">28.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Argenziano M, Dean DA, Moazami N, Williams M, <strong>Goldstein DJ</strong>, Rose EA, Spotnitz HM, Burkhoff D, Oz MC, Dickstein ML. <em>Inhaled nitric oxide does not alter systolic or diastolic myocardial function in a porcine model of heart failure</em>. J Thorac Cardiovasc Surg 1998;115:700-08.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">29.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Garfein E, Zuech N, Michler RE<em>.</em> <em>Mitral valve replacement and tricuspid annuloplasty following cardiac transplantation</em>. Ann Thorac Surg. 1997;63:1463-65.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">30.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, DeRosa C, Seldomridge JA, Weinberg AD, Oz MC, Smith CR. <em>Is aprotinin indicated for reoperative valvular surgery?.</em>&nbsp; J Heart Valve Dis 1997;6:88-92.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">31.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Argenziano M, Oz MC. <em>Permanent mechanical circulatory support: pitfalls and promises.</em> Contemporary Treatments in Cardiovascular Diseases 1997;2:209-25.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">32.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Flores R, and Todd G. <em>Rupture of non-aneurysmal atherosclerotic infrarenal aorta</em>. J Vasc Surg 1997;26:700-03.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">33.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Flores RM, <strong>Goldstein DJ</strong>, Sung RS, Steinglass K, Weinsten S, Chabot JA. <em>Transthoracic transdiaphragmatic excision of simultaneous lung and adrenal lesions</em>.&nbsp; Ann Thorac Surg 1998;65:833-34.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">34.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Slater JP, Lipsitz EC, Chen JM, Levin HR, Oz MC, <strong>Goldstein DJ</strong>, Ashton RC, Burkhoff D. <em>Systolic ventricular interaction in normal and diseased explanted human hearts.</em>&nbsp; J Thorac Cardiovasc Surg 1997;113:1091-99.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">35.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Choudhri A, Argenziano M, Ulmer B, Oz MC. <em>Repeat administration of aprotinin for staged cardiac transplantation.</em> J Circ Support 1998;1:27-30.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">36.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Argenziano M, <strong>Goldstein DJ</strong>, Catanese KA, Flannery M, Gardocki MT, Rose EA, Scully BE, Oz MC. <em>Management of infections involving the left ventricular assist device surface</em>. J Circ Support 1998;1:31-36.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">37.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Farman J, <strong>Goldstein DJ,</strong> Sugalski M, Moazami N, Amory S. <em>Bouveret&rsquo;s syndrome: diagnosis by helical CT scan.</em> Clinical Imaging 1998;22:240-42.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">38.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Harig B, <strong>Goldstein DJ</strong>, Rosen Y, Farman J. <em>Colonic obstruction due to sigmoid muscle hyperplasia.</em> Mt Sinai J Med 1999;66:106-8.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">39.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Argenziano M, Dean D, Moazami N, Williams M,<strong>Goldstein DJ</strong>, Cabreriza S, Burkhoff D, Smerling A, Rose EA, Oz MC, Dickstein M. <em>Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure</em>. J Thorac Cardiovasc Surg 1998;115:700-08.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">40.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Michler RE, <strong>Goldstein DJ</strong>. <em>Cardiac transplantation for primary cardiac neoplasms</em>.&nbsp; Seminars in Oncology 1997;24:534-39.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">41.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Losquadro W, Spotnitz HM. <em>Outpatient pacemaker procedures in orally anticoagulated patients</em>. PACE 1998;21:1730-34.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">42.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Oz MC, Rose EA. <em>Implantable left ventricular assist devices</em>. New Engl J Med 1998;339(21):1522-33.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">43.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Hart J, Cabreriza S, Jia CX, Umana J, <strong>Goldstein DJ</strong>, Hill-Edgar A, Weinberg AD, Galantowicz ME, Dickstein M, Burkhoff D, Rose EA, Spotnitz HM. <em>Left ventricular function in a porcine model of dilated cardiomyopathy during left ventricular reduction surgery</em>. Surg Forum 1998;49:246-8.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">44.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Rose EA, Moskowitz A, Packer M, Sollano J, Williams D, Tierney A, Heitjan D, Meier P, Ascheim D, Levitan R, Weinberg A, Stevenson L, Watson J, <strong>Goldstein D</strong>, Gelijns A. <em>Randomized evaluation of mechanical assistance for the treatment of congestive heart failure: rationale, design and endpoints.</em> Ann Thorac Surg 1999; 67:723-30.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">45.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Rabkin D, Spotnitz HM. <em>Unconventional approaches to cardiac pacing in patients with inaccessible cardiac chambers.</em> Ann Thorac Surg 1999;67:952-8.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">46.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Rabkin D, <strong>Goldstein DJ,</strong> Flores R, Benvenisty AI. <em>Spontaneous popliteal artery dissection.</em> J Vasc Surg 1999;29:737-40.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">47.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Oz MC. <em>Minimally invasive cardiac surgery: present status and future directions.</em> Curr Op in Cardiol. 1999:14:419-25.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">48.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Morales DLS, Catanese KA, Helman DN, Williams MR, Weinberg A, <strong>Goldstein DJ</strong>, Rose EA, Oz MC. <em>Six-year experience of caring for 44 LVAD patients at home: safe, economical and necessary.&nbsp;</em> J Thorac Cardiovasc Surg 2000;119:251-9.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">49.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Rabkin D, Sladen R, Dimango A, Steinglass K, <strong>Goldstein DJ</strong>.<em>Inhaled nitric oxide for the treatment of postpneumonectomy pulmonary edema.</em> Ann Thorac Surg 2001;72:272-4.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">50.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Oz MC. <em>Mechanical support for postcardiotomy cardiogenic shock</em>. Sem Thorac Cardiovasc Surg 2000;12:220-8.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">51.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Youssuf A, Karanam R, Prendergast T, Saunders C, Hertz S, Brener B, Sardari F, <strong>Goldstein DJ</strong>. <em>Combined off pump and carotid revascularization: early experience.&nbsp;</em> Ann Thorac Surg 2001;72:1542-5.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">52.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Kukuy E, <strong>Goldstein D</strong>, Rao V, Edwards N, Naka Y. <em>A simple method of creating LVAD outflow anastomosis</em>. Heart Surgery Forum 2002;6(1).</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">53.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>. Invited Commentary. In: <em>Ambulatory intraaortic balloon pump use as bridge to heart transplant.</em> Ann Thorac Surg&nbsp; 2002;74:751-2.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in;">54.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Beauford R, Luk B, Prendergast T, Sardari F, Burns P, Karanam R, Saunders C. <em>Multivessel off pump revascularization in patients with severe left ventricular dysfunction.</em> Eur J Cardiothorac 2003;24:72-80.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">55.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Beauford R, <strong>Goldstein D,</strong> Luk B, Prendergast T, Sardari F, Burns P, Karanam R, Saunders C. <em>Multivessel off pump revascularization in octagenarians.</em> Ann Thorac Surg 2003 ;76:12-7.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">56.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>. <em>Worldwide experience with the MicroMed DeBakey VAD as a bridge to transplantation.</em> Circulation2003;108:II272-7</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">57.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Beauford R.<em>Left ventricular assist devices and bleeding: adding insult to injury.</em> Ann Thorac Surg 2003;75:S42-7.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">58.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Beauford R, Saunders CR, <strong>Goldstein DJ.</strong> <em>&nbsp;Combined off-pump coronary revascularization and carotid endarterctomy.</em> J Cardiovasc Surg 2003;44:407-15</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">59.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Beauford R, Saunders C, Niemeier L, Lunceford T, Karanam R, Prendergast T, Shah S, Burns P, Sardari F and <strong>Goldstein D</strong>. <em>Is off pump revascularization better for patients with non-dialysis dependent renal insufficiency?</em>&nbsp; Heart Surg Forum 2004 7(2):E141-6.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">60.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Beauford R, Saunders C, Niemeier L, Lunceford T, Karanam R, Prendergast T, Shah S, Burns P, Sardari F and <strong>Goldstein D</strong>. <em>Multivessel off pump revascularization for patients with left main disease.</em> J Card Surg 2005:20:112-8.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">61.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Zucker M, Arroyo L, McCarthy P, Noon G. <em>Safety and efficacy trial of the MicroMed DeBakey VAD as a Bridge to transplantation</em>. J Am Coll Cardiol 2005;45:962-3</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 0in; text-autospace: none;">62.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Zucker MJ, Baran DA, Arroyo LH<strong>, Goldstein DJ</strong>, Neacy C, Mele L, WeinbergAD, Prendergast TW, Ribner HS: <em>De novo immunosuppression with sirolimus and&nbsp; tacrolimus in heart transplant recipients ccompared with cyclosporine and mycophenolate mofetil - a one year follow-up analysis</em>. Transpl Proc 2005;37:2231-9</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">63.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span>Baran DA, Gass Al, Galin I, Zucker M, Arroyo L, <strong>Goldstein DJ</strong>, Prendergast T, Lubitz S, Courtney M, Correa R, Chan M, Spielvogel D, Lansman S. <em>Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.</em> J Heart Lung Transpl 2005:24:1886-90.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">64.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>. Advances in Hematology: Coagulation and Thrombotic Complications Associated with Ventricular Assist Devices. Clin Adv Hematol Oncol 2005 3;10:766-8.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">65.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Smego D, Michler RE. Surgical aspects in congestive heart failure. Heart Fail Rev. 2006;11:171-192.</p>
<p style="margin-left: .3in; margin-bottom: 9.0pt; text-indent: -.3in; margin-right: 0in; margin-top: 12.0pt;">&nbsp;</p>
<p style="margin-bottom: 9.0pt;"><strong>Online Contributions</strong></p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">1.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dewey T, <strong>Goldstein DJ</strong>, Oz MC. TCI Heartmate insertion. Cardiothoracic Surgery Network: Expert&rsquo;s Techniques. Online: www.ctsnet.org/section/experts, 1999.</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">2.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Rose EA, <strong>Goldstein DJ</strong>. Role of Left Ventricular Assist Devices as a Bridge to Transplantation. In: Braunwald E, ed. Harrison&rsquo;s Online. McGraw-Hill 1999.</p>
<h1 style="font-family: 'Times New Roman'; margin-left: 0in; font-size: 12.0pt; margin-bottom: 9.0pt; margin-right: 0in; margin-top: 0in; page-break-after: avoid;"><span style="font-weight: normal;">&nbsp;</span></h1>
<h1 style="font-family: 'Times New Roman'; margin-left: 0in; font-size: 12.0pt; margin-bottom: 9.0pt; margin-right: 0in; margin-top: 0in; page-break-after: avoid;">Book Contributions</h1>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">1.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Costanzo MR, Rose EA. Novel Cardiac Replacement Therapies: A Vision for the Future. In: Management of End Stage Heart Disease. E.A.Rose and L.W Stevenson, editors. Lippincott-Raven, New York p.255-61. 1998</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">2.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Rose EA. Cardiac Allotransplantation. In: Management of End Stage Heart Disease. E.A.Rose and L.W Stevenson, editors. Lippincott-Raven, New York p.177-84. 1998</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">3.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Oz MC. What is Minimally Invasive ? In: Minimally Invasive Cardiac Surgery. Mehmet Oz and Daniel Goldstein, Editors. p.1-5. Humana Press Inc., Totowa, NJ.</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">4.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Lemole G, Choudhri A, Oz MC, <strong>Goldstein DJ</strong>, Gianguzzi R, Nguyen H. Economic Impact of Minimally Invasive Approaches. In: Minimally Invasive Cardiac Surgery. Mehmet Oz and Daniel Goldstein, Editors. p.165-72. Humana Press Inc., Totowa, NJ.</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">5.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>. The ThermoCardiosystems Device. In: Cardiac Assist Devices. Goldstein DJ, Oz MC, eds. Futura Publishing, Copyright 2000.</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">6.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Gibson M, Beauford R<strong>, Goldstein DJ.</strong> &nbsp;The Octopus Device. In: Minimally Invasive Cardiac Surgery. M. Oz, D Goldstein, Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">7.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Beauford R, Saunders CR. Beating Heart Revascularization in High-Risk Scenarios: The Patient with Severe Left Ventricular Dysfunction. In: Minimally Invasive Cardiac Surgery. D Goldstein, M. Oz. Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">8.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Sardari F, Beauford R, <strong>Goldstein DJ</strong>. Beating Heart Revascularization in High-Risk Scenarios: The Octagenarian Patient. In: Minimally Invasive Cardiac Surgery. D Goldstein, M. Oz. Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">9.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Zucker MJ, Pagani F, Frazier OH. Rotary Ventricular Assist Devices. In: International Society for Heart &amp; Lung Transplantation Monograph Series. Frazier OH, Kirklin JK, eds. Volume 1. p77-104. Copyright 2006</p>
<p style="line-height: 150%; margin-bottom: 9.0pt;"><strong>Books</strong></p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">1.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ</strong>, Argenziano M, editors. Department of Surgery Newsletter; Columbia Presbyterian Medical Center.</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">2.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Oz MC, <strong>Goldstein DJ,</strong> editors<strong>. <em>Contemporary Cardiology: Minimally Invasive Cardiac Surgery</em></strong>. Humana Press Inc., Totowa, NJ. Copyright 1999.</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">3.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Oz MC, editors. <em><strong>Cardiac Assist Devices.</strong></em> Futura Publishing. Copyright 2000.</p>
<p style="margin-left: .25in; margin-bottom: 9.0pt; text-indent: -.25in; margin-right: 0in; margin-top: 0in;">4.<span style="line-height: normal; font-family: 'Times New Roman'; font-size: 7.0pt; font-weight: normal; font-variant: normal; font-style: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong>Goldstein DJ,</strong> Oz MC, editors. <em><strong>Minimally Invasive Cardiac Surgery.</strong></em> Humana Press Inc., Totowa, NJ. Second Edition. Copyright 2003.</p>

EMR ID

4719

Biography

<p>Dr. Goldstein was raised in Caracas, Venezuela by a family of physicians. He attended Medical School at the Mount Sinai School of Medicine where he received the Alpha Omega Alpha Distinction and was recipient of the prestigious Lamport Biomedical Research Prize for his work on monoclonal antibodies. Dr. Goldstein went on to complete his General Surgery and Cardiothoracic Surgery training at Columbia Presbyterian Medical Center and Memorial Sloan Kettering Hospitals. During this time, he also completed one year of translational research in Cardiothoracic Surgery.</p><p>Dr. Goldstein received numerous research awards for his work on left ventricular assist devices and was recipient of teaching awards from both medical students and surgery residents. He was a recipient of the Claire Lucille Humanitarian Award for his work on children with congenital heart disease in Guatemala. Following completion of his training, he was recruited as Director of the Heart Transplantation and Mechanical Support programs at Newark Beth Israel Medical Center in New Jersey where during his five year tenure, he elevated that program to the 8th busiest center in the country. Most recently, he has joined the Department of Cardiothoracic Surgery at Montefiore Medical Center.</p><div></div>

Is Open Scheduling

Off